Clinical trial · Observational
Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study
NCT06098404CI-TRIAL-00099036recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cancer Patients
- description
- Patients diagnosed with cancer undergoing standard of care treatment.
Primary outcomes (2)
- measure
- Characterization of fecal microbiome using molecular methods at baseline
- timeFrame
- Baseline
- description
- Characterization of the fecal microbiome using a commercially available sampling kit and our lab's patented array for PCR at baseline
- measure
- Characterization of fecal microbiome using molecular methods at 6 months
- timeFrame
- 6 months
- description
- Characterization of the fecal microbiome using a commercially available sampling kit and our lab's patented array for PCR after 6 months of standard of care treatment.
Secondary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Current diagnosis of cancer. 2. Ages 18 and over. 3. Has access to a device (smart phone, computer, tablet) with internet access. 4. Participant is willing and able to give informed consent for participation in the study. Exclusion Criteria: 1. Females who are pregnant or lactating. 2. Other medical conditions or medications deemed exclusionary by the study investigators.
References
Publications (0)
Data not yet available
No reference posted for this study.